Heidbreder Christian 4
4 · Indivior Pharmaceuticals, Inc. · Filed Feb 12, 2026
Research Summary
AI-generated summary of this filing
Indivior (INDV) CSO Christian Heidbreder Receives RSU Awards
What Happened
- Christian Heidbreder, Chief Scientific Officer of Indivior (INDV), was granted a total of 166,187 restricted stock units (RSUs) in two awards. On Feb 9, 2026 he had 132,565 RSUs certified (derivative award) and on Feb 10, 2026 he received 33,622 RSUs. Both awards were reported as acquired at $0.00 (grant/award).
Key Details
- Transaction dates and types:
- Feb 9, 2026 — Grant/award (derivative): 132,565 RSUs (reported as acquired at $0.00). These were a conditional performance award granted Mar 3, 2023 and certified on Feb 9, 2026 (Footnote F2).
- Feb 10, 2026 — Grant/award: 33,622 RSUs (reported as acquired at $0.00). These RSUs vest in three equal annual installments beginning Feb 10, 2027 (Footnote F1).
- Vesting specifics:
- The 132,565 performance RSUs vest on Mar 3, 2026, subject to continued employment.
- The 33,622 time‑based RSUs vest in three equal annual installments starting Feb 10, 2027, subject to continued service.
- Shares owned after transaction: Not specified in the details provided here; see the Form 4 for total post-transaction holdings.
- Filing: Report filed Feb 12, 2026 (covers period ending Feb 9, 2026). No late filing flag indicated in the provided data.
- Exhibit: Form references Exhibit 24 (Power of Attorney).
Context
- These entries are awards (A) — not open-market purchases or sales — so they represent compensation/earned equity rather than a direct insider market vote. The larger item (132,565) was a performance-based award that only became certified on Feb 9, 2026 and is scheduled to vest on Mar 3, 2026 if employment conditions are met. The time-based RSUs (33,622) vest over three years starting Feb 10, 2027. For exact ownership after vesting or any tax-withholding adjustments, consult the full Form 4 and company disclosures.
Insider Transaction Report
Form 4
Heidbreder Christian
Chief Scientific Officer
Transactions
- Award
Common Stock
[F1]2026-02-10+33,622→ 190,762 total - Award
Performance Stock Units
[F2]2026-02-09+132,565→ 132,565 totalExercise: $0.00From: 2026-03-03→ Common Stock (132,565 underlying)
Footnotes (2)
- [F1]Reflects the grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock, vesting in three equal annual installments beginning on February 10, 2027, the first anniversary of the grant, subject to the Reporting Person's continued service with the Issuer.
- [F2]On March 3, 2023, the Reporting Person was granted a conditional award for 132,565 shares, subject to satisfaction of performance conditions, which were certified on February 9, 2026. The award vests, subject to continued employment conditions, on March 3, 2026.
Signature
/s/Alice Givens, Power of Attorney|2026-02-12